Mass Eye and Ear led the BRILLIANCE trial testing an experimental CRISPR-based gene editing medicine for a form of Leber Congenital Amaurosis, a condition that is a leading cause of childhood blindness. The researchers found that the treatment was safe and led to measurable improvements in 11 of the participants treated.
Learn more: masseyeandear.org/news/press-...